Company: HCTI
Filing Date: 2025-10-14
Form Type: DEF 14C
Source: 0001213900-25-098801
Chunk: 0

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-14
Form: DEF 14C
Chunk 0
---
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________ SCHEDULE 14C (Rule 14c -101 ) ___________________ SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities
Exchange Act of 1934 (Amendment No. ____) Check the appropriate box:

| ☐ |     | Preliminary Information Statement                                               |
| ☐ |     | Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) |
| ☒ |     | Definitive Information Statement                                                |

HEALTHCARE TRIANGLE, INC. (Name of Registrant as Specified In Its Charter) Payment of Filing Fee (Check all boxes that apply):

| ☒ |     | No fee required.                                                                                        |
| ☐ |     | Fee paid previously with preliminary materials.                                                         |
| ☐ |     | Fee computed on table below in exhibit required by Item 25(b) Exchange Act Rules 14a-6(i)(14) and 0-11. |

INFORMATION STATEMENT NOTICE OF STOCKHOLDER ACTION BY WRITTEN CONSENT NOTICE OF STOCKHOLDER ACTION BY WRITTEN CONSENT WE ARE NOT ASKING YOU FOR A PROXY, AND YOU ARE REQUESTED NOT TO SEND US
A PROXY. NO PROXY CARD HAS BEEN ENCLOSED WITH THIS INFORMATION STATEMENT. Dear Stockholders: This Information Statement is first being mailed on or about October14, 2025 to the stockholders of record of the outstanding shares of common stock of Healthcare Triangle, Inc., a Delaware corporation (“ Healthcare Triangle,” the “ Company,” “ we,” “ our,” or“ us”) as of the close of business on September19, 2025 (the “ Record Date”), pursuant to Rule 14c -2promulgated under the Securities Exchange Act of 1934, as amended (the “ Exchange Act”). The purpose of this Information Statement is to inform our stockholders of actions taken by written consent of Suresh Venkatachari, the holder of 81.82% of our voting power (the “ Majority Stockholder”). This Information Statement is being sent to you for informational purposes only and shall be considered the notice required under Rule 14c -2of the Exchange Act and Section 228(e) of the Delaware General Corporation Law (“ GCL”). The Majority Stockholder approved and authorized the issuance of 1,388,041